KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Preferred Dividend Payments (2023 - 2025)

Evolent Health has reported Preferred Dividend Payments over the past 3 years, most recently at $6.1 million for Q3 2025.

  • Quarterly results put Preferred Dividend Payments at $6.1 million for Q3 2025, down 25.06% from a year ago — trailing twelve months through Dec 2025 was $44.9 million (up 41.03% YoY), and the annual figure for FY2025 was $44.9 million, up 41.03%.
  • Preferred Dividend Payments for Q3 2025 was $6.1 million at Evolent Health, down from $31.2 million in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for EVH hit a ceiling of $31.2 million in Q2 2025 and a floor of $6.1 million in Q3 2025.
  • Median Preferred Dividend Payments over the past 3 years was $7.9 million (2023), compared with a mean of $9.6 million.
  • Peak annual rise in Preferred Dividend Payments hit 290.94% in 2025, while the deepest fall reached 25.06% in 2025.
  • Evolent Health's Preferred Dividend Payments stood at $8.0 million in 2023, then dropped by 2.14% to $7.8 million in 2024, then decreased by 22.36% to $6.1 million in 2025.
  • The last three reported values for Preferred Dividend Payments were $6.1 million (Q3 2025), $31.2 million (Q2 2025), and $7.6 million (Q1 2025) per Business Quant data.